{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T02:54:39Z","timestamp":1783652079736,"version":"3.55.0"},"reference-count":101,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,10,31]],"date-time":"2022-10-31T00:00:00Z","timestamp":1667174400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,10,31]],"date-time":"2022-10-31T00:00:00Z","timestamp":1667174400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004586","name":"Funda\u00e7\u00e3o Carlos Chagas Filho de Amparo \u00e0 Pesquisa do Estado do Rio de Janeiro","doi-asserted-by":"publisher","award":["E-26\/210.450\/2019"],"award-info":[{"award-number":["E-26\/210.450\/2019"]}],"id":[{"id":"10.13039\/501100004586","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Discovered as a contaminant of adenovirus stocks in the 1960s, adeno-associated virus (AAV) is a mono-stranded DNA virus that depends on helper factors to replicate. Even though AAV is endemic in the human population (35\u201380%), it is remarkable that many issues concerning the natural infection by this virus remain unanswered. In this study, we reflect on the main basic aspects of AAV biology and provide an overview of the studies exploring the impact of AAV infection on human health, focusing on three major research areas including, (i) cervical and (ii) liver cancer, and (iii) reproductive system disorders. Conflicting results have been obtained into the association of AAV infection with the occurrence of adverse reproductive outcomes, such as placental complications, spontaneous abortion, and fertility disorders, or with a protective role in HPV-related cervical carcinogenesis. Noteworthy, recent reports have identified AAV insertional mutagenesis as a novel risk factor for the development of hepatocellular carcinoma. This latest finding raises concern regarding the widespread usage of AAV vectors in liver-targeted gene therapy.<\/jats:p>","DOI":"10.1186\/s12985-022-01900-4","type":"journal-article","created":{"date-parts":[[2022,10,31]],"date-time":"2022-10-31T18:11:04Z","timestamp":1667239864000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Adeno-associated virus infection and its impact in human health: an overview"],"prefix":"10.1186","volume":"19","author":[{"given":"Tha\u00eds B","family":"Sant\u2019Anna","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia M","family":"Araujo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,31]]},"reference":[{"key":"1900_CR1","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1126\/science.149.3685.754","volume":"149","author":"RW Atchison","year":"1965","unstructured":"Atchison RW, Casto BC, Hammon WM. Adenovirus-Associated Defective Virus Particles. Science. 1965;149:754\u20136.","journal-title":"Science"},{"key":"1900_CR2","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1073\/pnas.55.6.1467","volume":"55","author":"MD Hoggan","year":"1966","unstructured":"Hoggan MD, Blacklow NR, Rowe WP. Studies of small DNA viruses found in various adenovirus preparations: physical, biological, and immunological characteristics. Proc Natl Acad Sci U S A. 1966;55:1467\u201374.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1900_CR3","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1038\/mt.2012.194","volume":"20","author":"S Yla-Herttuala","year":"2012","unstructured":"Yla-Herttuala S. Endgame: glybera finally recommended for approval as the first gene therapy drug in the European union. Mol Ther. 2012;20:1831\u20132.","journal-title":"Mol Ther"},{"key":"1900_CR4","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1089\/hum.2017.009","volume":"28","author":"RJ Chandler","year":"2017","unstructured":"Chandler RJ, Sands MS, Venditti CP. Recombinant Adeno-Associated Viral Integration and Genotoxicity: Insights from Animal Models. Hum Gene Ther. 2017;28:314\u201322.","journal-title":"Hum Gene Ther"},{"key":"1900_CR5","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.coviro.2016.08.003","volume":"21","author":"A Srivastava","year":"2016","unstructured":"Srivastava A. In vivo tissue-tropism of adeno-associated viral vectors. Curr Opin Virol. 2016;21:75\u201380.","journal-title":"Curr Opin Virol"},{"key":"1900_CR6","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1086\/595830","volume":"199","author":"R Calcedo","year":"2009","unstructured":"Calcedo R, Vandenberghe LH, Gao G, Lin J, Wilson JM. Worldwide epidemiology of neutralizing antibodies to adeno-associated viruses. J Infect Dis. 2009;199:381\u201390.","journal-title":"J Infect Dis"},{"key":"1900_CR7","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1002\/(SICI)1096-9071(199911)59:3<406::AID-JMV22>3.0.CO;2-N","volume":"59","author":"K Erles","year":"1999","unstructured":"Erles K, Sebokova P, Schlehofer JR. Update on the prevalence of serum antibodies (IgG and IgM) to adeno-associated virus (AAV). J Med Virol. 1999;59:406\u201311.","journal-title":"J Med Virol"},{"key":"1900_CR8","doi-asserted-by":"crossref","unstructured":"Meier AF, Fraefel C, Seyffert M. The Interplay between Adeno-Associated Virus and its Helper Viruses. Viruses 2020, 12.","DOI":"10.3390\/v12060662"},{"key":"1900_CR9","doi-asserted-by":"crossref","unstructured":"Wang Z, Deng X, Zou W, Engelhardt JF, Yan Z, Qiu J. Human Bocavirus 1 Is a Novel Helper for Adeno-associated Virus Replication. J Virol 2017, 91.","DOI":"10.1128\/JVI.00710-17"},{"key":"1900_CR10","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1128\/jvi.61.4.972-981.1987","volume":"61","author":"B Yakobson","year":"1987","unstructured":"Yakobson B, Koch T, Winocour E. Replication of adeno-associated virus in synchronized cells without the addition of a helper virus. J Virol. 1987;61:972\u201381.","journal-title":"J Virol"},{"key":"1900_CR11","first-page":"3123","volume":"48","author":"AO Yalkinoglu","year":"1988","unstructured":"Yalkinoglu AO, Heilbronn R, Burkle A, Schlehofer JR, zur Hausen H. DNA amplification of adeno-associated virus as a response to cellular genotoxic stress. Cancer Res. 1988;48:3123\u20139.","journal-title":"Cancer Res"},{"key":"1900_CR12","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1099\/0022-1317-83-5-973","volume":"83","author":"A Girod","year":"2002","unstructured":"Girod A, Wobus CE, Zadori Z, Ried M, Leike K, Tijssen P, Kleinschmidt JA, Hallek M. The VP1 capsid protein of adeno-associated virus type 2 is carrying a phospholipase A2 domain required for virus infectivity. J Gen Virol. 2002;83:973\u20138.","journal-title":"J Gen Virol"},{"key":"1900_CR13","doi-asserted-by":"publisher","first-page":"6595","DOI":"10.1128\/JVI.78.12.6595-6609.2004","volume":"78","author":"KH Warrington Jr","year":"2004","unstructured":"Warrington KH Jr, Gorbatyuk OS, Harrison JK, Opie SR, Zolotukhin S, Muzyczka N. Adeno-associated virus type 2 VP2 capsid protein is nonessential and can tolerate large peptide insertions at its N terminus. J Virol. 2004;78:6595\u2013609.","journal-title":"J Virol"},{"key":"1900_CR14","doi-asserted-by":"publisher","first-page":"10405","DOI":"10.1073\/pnas.162250899","volume":"99","author":"Q Xie","year":"2002","unstructured":"Xie Q, Bu W, Bhatia S, Hare J, Somasundaram T, Azzi A, Chapman MS. The atomic structure of adeno-associated virus (AAV-2), a vector for human gene therapy. Proc Natl Acad Sci U S A. 2002;99:10405\u201310.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1900_CR15","doi-asserted-by":"publisher","first-page":"12260","DOI":"10.1128\/JVI.01304-07","volume":"81","author":"HJ Nam","year":"2007","unstructured":"Nam HJ, Lane MD, Padron E, Gurda B, McKenna R, Kohlbrenner E, Aslanidi G, Byrne B, Muzyczka N, Zolotukhin S, Agbandje-McKenna M. Structure of adeno-associated virus serotype 8, a gene therapy vector. J Virol. 2007;81:12260\u201371.","journal-title":"J Virol"},{"key":"1900_CR16","doi-asserted-by":"publisher","first-page":"5047","DOI":"10.1128\/JVI.79.8.5047-5058.2005","volume":"79","author":"E Padron","year":"2005","unstructured":"Padron E, Bowman V, Kaludov N, Govindasamy L, Levy H, Nick P, McKenna R, Muzyczka N, Chiorini JA, Baker TS, Agbandje-McKenna M. Structure of adeno-associated virus type 4. J Virol. 2005;79:5047\u201358.","journal-title":"J Virol"},{"key":"1900_CR17","doi-asserted-by":"publisher","first-page":"3361","DOI":"10.1128\/JVI.78.7.3361-3371.2004","volume":"78","author":"RW Walters","year":"2004","unstructured":"Walters RW, Agbandje-McKenna M, Bowman VD, Moninger TO, Olson NH, Seiler M, Chiorini JA, Baker TS, Zabner J. Structure of adeno-associated virus serotype 5. J Virol. 2004;78:3361\u201371.","journal-title":"J Virol"},{"key":"1900_CR18","doi-asserted-by":"publisher","first-page":"3101","DOI":"10.2741\/2912","volume":"13","author":"J Qiu","year":"2008","unstructured":"Qiu J, Pintel D. Processing of adeno-associated virus RNA. Front Biosci. 2008;13:3101\u201315.","journal-title":"Front Biosci"},{"key":"1900_CR19","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1038\/gt.2012.6","volume":"19","author":"M Nonnenmacher","year":"2012","unstructured":"Nonnenmacher M, Weber T. Intracellular transport of recombinant adeno-associated virus vectors. Gene Ther. 2012;19:649\u201358.","journal-title":"Gene Ther"},{"key":"1900_CR20","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1038\/sj.mt.6300053","volume":"15","author":"B Akache","year":"2007","unstructured":"Akache B, Grimm D, Shen X, Fuess S, Yant SR, Glazer DS, Park J, Kay MA. A two-hybrid screen identifies cathepsins B and L as uncoating factors for adeno-associated virus 2 and 8. Mol Ther. 2007;15:330\u20139.","journal-title":"Mol Ther"},{"key":"1900_CR21","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/nature16465","volume":"530","author":"S Pillay","year":"2016","unstructured":"Pillay S, Meyer NL, Puschnik AS, Davulcu O, Diep J, Ishikawa Y, Jae LT, Wosen JE, Nagamine CM, Chapman MS, Carette JE. An essential receptor for adeno-associated virus infection. Nature. 2016;530:108\u201312.","journal-title":"Nature"},{"key":"1900_CR22","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1006\/viro.1999.0010","volume":"264","author":"J Qiu","year":"1999","unstructured":"Qiu J, Brown KE. Integrin alphaVbeta5 is not involved in adeno-associated virus type 2 (AAV2) infection. Virology. 1999;264:436\u201340.","journal-title":"Virology"},{"key":"1900_CR23","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/4768","volume":"5","author":"C Summerford","year":"1999","unstructured":"Summerford C, Bartlett JS, Samulski RJ. AlphaVbeta5 integrin: a co-receptor for adeno-associated virus type 2 infection. Nat Med. 1999;5:78\u201382.","journal-title":"Nat Med"},{"key":"1900_CR24","doi-asserted-by":"publisher","first-page":"14781","DOI":"10.1128\/JVI.79.23.14781-14792.2005","volume":"79","author":"CL Chen","year":"2005","unstructured":"Chen CL, Jensen RL, Schnepp BC, Connell MJ, Shell R, Sferra TJ, Bartlett JS, Clark KR, Johnson PR. Molecular characterization of adeno-associated viruses infecting children. J Virol. 2005;79:14781\u201392.","journal-title":"J Virol"},{"key":"1900_CR25","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.ymthe.2019.11.005","volume":"28","author":"AM Dudek","year":"2020","unstructured":"Dudek AM, Zabaleta N, Zinn E, Pillay S, Zengel J, Porter C, Franceschini JS, Estelien R, Carette JE, Zhou GL, Vandenberghe LH. GPR108 Is a Highly Conserved AAV Entry Factor. Mol Ther. 2020;28:367\u201381.","journal-title":"Mol Ther"},{"key":"1900_CR26","doi-asserted-by":"publisher","first-page":"2777","DOI":"10.1128\/JVI.74.6.2777-2785.2000","volume":"74","author":"JS Bartlett","year":"2000","unstructured":"Bartlett JS, Wilcher R, Samulski RJ. Infectious entry pathway of adeno-associated virus and adeno-associated virus vectors. J Virol. 2000;74:2777\u201385.","journal-title":"J Virol"},{"key":"1900_CR27","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.chom.2011.10.014","volume":"10","author":"M Nonnenmacher","year":"2011","unstructured":"Nonnenmacher M, Weber T. Adeno-associated virus 2 infection requires endocytosis through the CLIC\/GEEC pathway. Cell Host Microbe. 2011;10:563\u201376.","journal-title":"Cell Host Microbe"},{"key":"1900_CR28","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1128\/JVI.02520-14","volume":"89","author":"ME Nonnenmacher","year":"2015","unstructured":"Nonnenmacher ME, Cintrat JC, Gillet D, Weber T. Syntaxin 5-dependent retrograde transport to the trans-Golgi network is required for adeno-associated virus transduction. J Virol. 2015;89:1673\u201387.","journal-title":"J Virol"},{"key":"1900_CR29","doi-asserted-by":"publisher","first-page":"11040","DOI":"10.1128\/JVI.01056-06","volume":"80","author":"F Sonntag","year":"2006","unstructured":"Sonntag F, Bleker S, Leuchs B, Fischer R, Kleinschmidt JA. Adeno-associated virus type 2 capsids with externalized VP1\/VP2 trafficking domains are generated prior to passage through the cytoplasm and are maintained until uncoating occurs in the nucleus. J Virol. 2006;80:11040\u201354.","journal-title":"J Virol"},{"key":"1900_CR30","doi-asserted-by":"publisher","first-page":"5199","DOI":"10.1128\/JVI.02723-05","volume":"80","author":"JC Grieger","year":"2006","unstructured":"Grieger JC, Snowdy S, Samulski RJ. Separate basic region motifs within the adeno-associated virus capsid proteins are essential for infectivity and assembly. J Virol. 2006;80:5199\u2013210.","journal-title":"J Virol"},{"key":"1900_CR31","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.virol.2010.09.025","volume":"409","author":"S Stahnke","year":"2011","unstructured":"Stahnke S, Lux K, Uhrig S, Kreppel F, Hosel M, Coutelle O, Ogris M, Hallek M, Buning H. Intrinsic phospholipase A2 activity of adeno-associated virus is involved in endosomal escape of incoming particles. Virology. 2011;409:77\u201383.","journal-title":"Virology"},{"key":"1900_CR32","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/S1534-5807(01)00031-4","volume":"1","author":"Z Zadori","year":"2001","unstructured":"Zadori Z, Szelei J, Lacoste MC, Li Y, Gariepy S, Raymond P, Allaire M, Nabi IR, Tijssen P. A viral phospholipase A2 is required for parvovirus infectivity. Dev Cell. 2001;1:291\u2013302.","journal-title":"Dev Cell"},{"key":"1900_CR33","doi-asserted-by":"publisher","first-page":"2632","DOI":"10.1128\/JVI.02309-08","volume":"83","author":"JS Johnson","year":"2009","unstructured":"Johnson JS, Samulski RJ. Enhancement of adeno-associated virus infection by mobilizing capsids into and out of the nucleolus. J Virol. 2009;83:2632\u201344.","journal-title":"J Virol"},{"key":"1900_CR34","doi-asserted-by":"publisher","first-page":"3631","DOI":"10.1038\/s41598-019-40071-1","volume":"9","author":"A Rossi","year":"2019","unstructured":"Rossi A, Dupaty L, Aillot L, Zhang L, Gallien C, Hallek M, Odenthal M, Adriouch S, Salvetti A, Buning H. Vector uncoating limits adeno-associated viral vector-mediated transduction of human dendritic cells and vector immunogenicity. Sci Rep. 2019;9:3631.","journal-title":"Sci Rep"},{"key":"1900_CR35","doi-asserted-by":"publisher","first-page":"3110","DOI":"10.1128\/JVI.78.6.3110-3122.2004","volume":"78","author":"CE Thomas","year":"2004","unstructured":"Thomas CE, Storm TA, Huang Z, Kay MA. Rapid uncoating of vector genomes is the key to efficient liver transduction with pseudotyped adeno-associated virus vectors. J Virol. 2004;78:3110\u201322.","journal-title":"J Virol"},{"key":"1900_CR36","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1128\/jvi.33.2.739-748.1980","volume":"33","author":"AK Cheung","year":"1980","unstructured":"Cheung AK, Hoggan MD, Hauswirth WW, Berns KI. Integration of the adeno-associated virus genome into cellular DNA in latently infected human Detroit 6 cells. J Virol. 1980;33:739\u201348.","journal-title":"J Virol"},{"key":"1900_CR37","doi-asserted-by":"publisher","first-page":"12849","DOI":"10.1073\/pnas.96.22.12849","volume":"96","author":"J Dyall","year":"1999","unstructured":"Dyall J, Szabo P, Berns KI. Adeno-associated virus (AAV) site-specific integration: formation of AAV-AAVS1 junctions in an in vitro system. Proc Natl Acad Sci U S A. 1999;96:12849\u201354.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1900_CR38","doi-asserted-by":"publisher","first-page":"7554","DOI":"10.1128\/JVI.76.15.7554-7559.2002","volume":"76","author":"D Huser","year":"2002","unstructured":"Huser D, Weger S, Heilbronn R. Kinetics and frequency of adeno-associated virus site-specific integration into human chromosome 19 monitored by quantitative real-time PCR. J Virol. 2002;76:7554\u20139.","journal-title":"J Virol"},{"key":"1900_CR39","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1146\/annurev.genet.37.110801.143717","volume":"38","author":"DM McCarty","year":"2004","unstructured":"McCarty DM, Young SM Jr, Samulski RJ. Integration of adeno-associated virus (AAV) and recombinant AAV vectors. Annu Rev Genet. 2004;38:819\u201345.","journal-title":"Annu Rev Genet"},{"key":"1900_CR40","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1089\/hum.2009.214","volume":"21","author":"X Sun","year":"2010","unstructured":"Sun X, Lu Y, Bish LT, Calcedo R, Wilson JM, Gao G. Molecular analysis of vector genome structures after liver transduction by conventional and self-complementary adeno-associated viral serotype vectors in murine and nonhuman primate models. Hum Gene Ther. 2010;21:750\u201361.","journal-title":"Hum Gene Ther"},{"key":"1900_CR41","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1128\/jvi.71.2.1079-1088.1997","volume":"71","author":"DJ Pereira","year":"1997","unstructured":"Pereira DJ, McCarty DM, Muzyczka N. The adeno-associated virus (AAV) Rep protein acts as both a repressor and an activator to regulate AAV transcription during a productive infection. J Virol. 1997;71:1079\u201388.","journal-title":"J Virol"},{"key":"1900_CR42","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1089\/hum.2005.16.551","volume":"16","author":"S Zolotukhin","year":"2005","unstructured":"Zolotukhin S. Production of recombinant adeno-associated virus vectors. Hum Gene Ther. 2005;16:551\u20137.","journal-title":"Hum Gene Ther"},{"issue":"Pt 4","key":"1900_CR43","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1099\/0022-1317-73-4-961","volume":"73","author":"Z Grossman","year":"1992","unstructured":"Grossman Z, Mendelson E, Brok-Simoni F, Mileguir F, Leitner Y, Rechavi G, Ramot B. Detection of adeno-associated virus type 2 in human peripheral blood cells. J Gen Virol. 1992;73(Pt 4):961\u20136.","journal-title":"J Gen Virol"},{"key":"1900_CR44","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1038\/ng.3389","volume":"47","author":"JC Nault","year":"2015","unstructured":"Nault JC, Datta S, Imbeaud S, Franconi A, Mallet M, Couchy G, Letouze E, Pilati C, Verret B, Blanc JF, et al. Recurrent AAV2-related insertional mutagenesis in human hepatocellular carcinomas. Nat Genet. 2015;47:1187\u201393.","journal-title":"Nat Genet"},{"key":"1900_CR45","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1080\/15513815.2019.1576817","volume":"38","author":"Z Sayyadi-Dehno","year":"2019","unstructured":"Sayyadi-Dehno Z, Seyed Khorrami SM, Ghavami N, Ghotbi-Zadeh F, Khushideh M, Hosseini M, Malekshahi SS, Shafiei-Jandaghi NZ. Molecular Detection of Adeno-Associated Virus DNA in Cases of Spontaneous and Therapeutic Abortion. Fetal Pediatr Pathol. 2019;38:206\u201314.","journal-title":"Fetal Pediatr Pathol"},{"key":"1900_CR46","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1002\/jmv.1890440218","volume":"44","author":"E Tobiasch","year":"1994","unstructured":"Tobiasch E, Rabreau M, Geletneky K, Larue-Charlus S, Severin F, Becker N, Schlehofer JR. Detection of adeno-associated virus DNA in human genital tissue and in material from spontaneous abortion. J Med Virol. 1994;44:215\u201322.","journal-title":"J Med Virol"},{"key":"1900_CR47","doi-asserted-by":"publisher","first-page":"6381","DOI":"10.1128\/JVI.78.12.6381-6388.2004","volume":"78","author":"G Gao","year":"2004","unstructured":"Gao G, Vandenberghe LH, Alvira MR, Lu Y, Calcedo R, Zhou X, Wilson JM. Clades of Adeno-associated viruses are widely disseminated in human tissues. J Virol. 2004;78:6381\u20138.","journal-title":"J Virol"},{"key":"1900_CR48","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1006\/viro.1998.9226","volume":"247","author":"CM Walz","year":"1998","unstructured":"Walz CM, Anisi TR, Schlehofer JR, Gissmann L, Schneider A, Muller M. Detection of infectious adeno-associated virus particles in human cervical biopsies. Virology. 1998;247:97\u2013105.","journal-title":"Virology"},{"key":"1900_CR49","unstructured":"International Agency for Research on Cancer. Globocan 2020. 23-Cervix-uteri-fact-sheet.pdf. https:\/\/gco.iarc.fr\/today\/data\/factsheets\/cancers\/23-Cervix-uteri-fact-sheet.pdf."},{"key":"1900_CR50","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1093\/jnci\/92.9.690","volume":"92","author":"H zur Hausen","year":"2000","unstructured":"zur Hausen H. Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis. J Natl Cancer Inst. 2000;92:690\u20138.","journal-title":"J Natl Cancer Inst"},{"key":"1900_CR51","doi-asserted-by":"crossref","unstructured":"Scheffner M, Werness BA, Huibregtse JM, Levine AJ, Howley PM. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 1990, 63:1129\u20131136.","DOI":"10.1016\/0092-8674(90)90409-8"},{"key":"1900_CR52","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1126\/science.2157286","volume":"248","author":"BA Werness","year":"1990","unstructured":"Werness BA, Levine AJ, Howley PM. Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science. 1990;248:76\u20139.","journal-title":"Science"},{"key":"1900_CR53","first-page":"2278","volume":"54","author":"PL Hermonat","year":"1994","unstructured":"Hermonat PL. Adeno-associated virus inhibits human papillomavirus type 16: a viral interaction implicated in cervical cancer. Cancer Res. 1994;54:2278\u201381.","journal-title":"Cancer Res"},{"key":"1900_CR54","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1006\/gyno.1997.4789","volume":"66","author":"PL Hermonat","year":"1997","unstructured":"Hermonat PL, Plott RT, Santin AD, Parham GP, Flick JT. Adeno-associated virus Rep78 inhibits oncogenic transformation of primary human keratinocytes by a human papillomavirus type 16-ras chimeric. Gynecol Oncol. 1997;66:487\u201394.","journal-title":"Gynecol Oncol"},{"key":"1900_CR55","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1006\/viro.2001.1256","volume":"293","author":"CM Walz","year":"2002","unstructured":"Walz CM, Correa-Ochoa MM, Muller M, Schlehofer JR. Adenoassociated virus type 2-induced inhibition of the human papillomavirus type 18 promoter in transgenic mice. Virology. 2002;293:172\u201381.","journal-title":"Virology"},{"key":"1900_CR56","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/0304-3835(94)90193-7","volume":"81","author":"PL Hermonat","year":"1994","unstructured":"Hermonat PL. Down-regulation of the human c-fos and c-myc proto-oncogene promoters by adeno-associated virus Rep78. Cancer Lett. 1994;81:129\u201336.","journal-title":"Cancer Lett"},{"key":"1900_CR57","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/0002-9378(76)90472-5","volume":"126","author":"HD Mayor","year":"1976","unstructured":"Mayor HD, Drake S, Stahmann J, Mumford DM. Antibodies to adeno-associated satellite virus and herpes simplex in sera from cancer patients and normal adults. Am J Obstet Gynecol. 1976;126:100\u20134.","journal-title":"Am J Obstet Gynecol"},{"key":"1900_CR58","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/0042-6822(84)90272-1","volume":"134","author":"B Georg-Fries","year":"1984","unstructured":"Georg-Fries B, Biederlack S, Wolf J, zur Hausen H. Analysis of proteins, helper dependence, and seroepidemiology of a new human parvovirus. Virology. 1984;134:64\u201371.","journal-title":"Virology"},{"key":"1900_CR59","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1006\/exmp.2000.2347","volume":"70","author":"AL Coker","year":"2001","unstructured":"Coker AL, Russell RB, Bond SM, Pirisi L, Liu Y, Mane M, Kokorina N, Gerasimova T, Hermonat PL. Adeno-associated virus is associated with a lower risk of high-grade cervical neoplasia. Exp Mol Pathol. 2001;70:83\u20139.","journal-title":"Exp Mol Pathol"},{"key":"1900_CR60","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1097\/CEJ.0b013e3282b6fd2e","volume":"17","author":"T Agorastos","year":"2008","unstructured":"Agorastos T, Chrisafi S, Lambropoulos AF, Mikos T, Constandinides TC, Schlehofer JR, Schlehofer B, Kotsis A, Bontis JN. Adeno-associated virus infection and cervical neoplasia: is there a protective role against human papillomavirus-related carcinogenesis? Eur J Cancer Prev. 2008;17:364\u20138.","journal-title":"Eur J Cancer Prev"},{"key":"1900_CR61","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1258\/ijsa.2009.009150","volume":"23","author":"LB Freitas","year":"2012","unstructured":"Freitas LB, Tonani de Mattos A, Lima BM, Miranda AE, Spano LC. Adeno-associated virus may play a protective role against human papillomavirus-induced cervical lesions independent of HIV serostatus. Int J STD AIDS. 2012;23:258\u201361.","journal-title":"Int J STD AIDS"},{"key":"1900_CR62","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1002\/(SICI)1096-9071(199909)59:1<60::AID-JMV10>3.0.CO;2-8","volume":"59","author":"HD Strickler","year":"1999","unstructured":"Strickler HD, Viscidi R, Escoffery C, Rattray C, Kotloff KL, Goldberg J, Manns A, Rabkin C, Daniel R, Hanchard B, et al. Adeno-associated virus and development of cervical neoplasia. J Med Virol. 1999;59:60\u20135.","journal-title":"J Med Virol"},{"key":"1900_CR63","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1006\/gyno.2000.5880","volume":"78","author":"KO Odunsi","year":"2000","unstructured":"Odunsi KO, van Ee CC, Ganesan TS, Shelling AN. Evaluation of the possible protective role of adeno-associated virus type 2 infection in HPV-associated premalignant disease of the cervix. Gynecol Oncol. 2000;78:342\u20135.","journal-title":"Gynecol Oncol"},{"key":"1900_CR64","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/S0090-8258(03)00008-8","volume":"89","author":"WS Ahn","year":"2003","unstructured":"Ahn WS, Bae SM, Chung JE, Lee HK, Kim BK, Lee JM, Namkoong SE, Kim CK, Sin J. Evaluation of adenoassociated virus 2 and human papilloma virus 16 and 18 infection in cervical cancer biopsies. Gynecol Oncol. 2003;89:105\u201311.","journal-title":"Gynecol Oncol"},{"key":"1900_CR65","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1128\/JCM.42.3.1341-1344.2004","volume":"42","author":"M Grce","year":"2004","unstructured":"Grce M, Husnjak K, Matovina M, Milutin N, Magdic L, Husnjak O, Pavelic K. Human papillomavirus, cytomegalovirus, and adeno-associated virus infections in pregnant and nonpregnant women with cervical intraepithelial neoplasia. J Clin Microbiol. 2004;42:1341\u20134.","journal-title":"J Clin Microbiol"},{"key":"1900_CR66","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1038\/sj.bjc.6603179","volume":"94","author":"BY Zheng","year":"2006","unstructured":"Zheng BY, Li XD, Wiklund F, Chowdhry S, Angstrom T, Hallmans G, Dillner J, Wallin KL. Detection of adeno-associated virus type 2 genome in cervical carcinoma. Br J Cancer. 2006;94:1913\u20137.","journal-title":"Br J Cancer"},{"key":"1900_CR67","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.prp.2017.02.010","volume":"213","author":"NZ Shafiei-Jandaghi","year":"2017","unstructured":"Shafiei-Jandaghi NZ, Yavarian J, Faghihloo E, Ghavami N, Ghalejoogh ZY, Kiani SJ, Malekshahi SS, Shahsiah R, Jahanzad E, Hosseini M, Azad TM. Prevalence of adeno-associated virus and human papillomavirus DNA in Iranian women with and without cervical cancer. Pathol Res Pract. 2017;213:457\u201360.","journal-title":"Pathol Res Pract"},{"key":"1900_CR68","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1093\/humupd\/dmv041","volume":"22","author":"S Giakoumelou","year":"2016","unstructured":"Giakoumelou S, Wheelhouse N, Cuschieri K, Entrican G, Howie SE, Horne AW. The role of infection in miscarriage. Hum Reprod Update. 2016;22:116\u201333.","journal-title":"Hum Reprod Update"},{"key":"1900_CR69","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1093\/humrep\/dem360","volume":"23","author":"F Arechavaleta-Velasco","year":"2008","unstructured":"Arechavaleta-Velasco F, Gomez L, Ma Y, Zhao J, McGrath CM, Sammel MD, Nelson DB, Parry S. Adverse reproductive outcomes in urban women with adeno-associated virus-2 infections in early pregnancy. Hum Reprod. 2008;23:29\u201336.","journal-title":"Hum Reprod"},{"key":"1900_CR70","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.2353\/ajpath.2006.050781","volume":"168","author":"F Arechavaleta-Velasco","year":"2006","unstructured":"Arechavaleta-Velasco F, Ma Y, Zhang J, McGrath CM, Parry S. Adeno-associated virus-2 (AAV-2) causes trophoblast dysfunction, and placental AAV-2 infection is associated with preeclampsia. Am J Pathol. 2006;168:1951\u20139.","journal-title":"Am J Pathol"},{"key":"1900_CR71","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1053\/plac.2002.0827","volume":"23","author":"K Kiehl","year":"2002","unstructured":"Kiehl K, Schlehofer JR, Schultz R, Zugaib M, Armbruster-Moraes E. Adeno-associated virus DNA in human gestational trophoblastic disease. Placenta. 2002;23:410\u20135.","journal-title":"Placenta"},{"key":"1900_CR72","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1002\/jmv.21841","volume":"82","author":"CC Pereira","year":"2010","unstructured":"Pereira CC, de Freitas LB, de Vargas PR, de Azevedo ML, do Nascimento JP, Spano LC. Molecular detection of adeno-associated virus in cases of spontaneous and intentional human abortion. J Med Virol. 2010;82:1689\u201393.","journal-title":"J Med Virol"},{"issue":"Pt 10","key":"1900_CR73","doi-asserted-by":"publisher","first-page":"2655","DOI":"10.1099\/0022-1317-75-10-2655","volume":"75","author":"V Botquin","year":"1994","unstructured":"Botquin V, Cid-Arregui A, Schlehofer JR. Adeno-associated virus type 2 interferes with early development of mouse embryos. J Gen Virol. 1994;75(Pt 10):2655\u201362.","journal-title":"J Gen Virol"},{"key":"1900_CR74","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1159\/000149172","volume":"14","author":"BV Lipps","year":"1980","unstructured":"Lipps BV, Mayor HD. Transplacental infection with adeno-associated virus type 1 in mice. Intervirology. 1980;14:118\u201323.","journal-title":"Intervirology"},{"issue":"Pt 8","key":"1900_CR75","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1099\/0022-1317-78-8-1957","volume":"78","author":"O Malhomme","year":"1997","unstructured":"Malhomme O, Dutheil N, Rabreau M, Armbruster-Moraes E, Schlehofer JR, Dupressoir T. Human genital tissues containing DNA of adeno-associated virus lack DNA sequences of the helper viruses adenovirus, herpes simplex virus or cytomegalovirus but frequently contain human papillomavirus DNA. J Gen Virol. 1997;78(Pt 8):1957\u201362.","journal-title":"J Gen Virol"},{"key":"1900_CR76","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1111\/j.1749-6632.2001.tb03798.x","volume":"943","author":"H Koi","year":"2001","unstructured":"Koi H, Zhang J, Parry S. The mechanisms of placental viral infection. Ann N Y Acad Sci. 2001;943:148\u201356.","journal-title":"Ann N Y Acad Sci"},{"key":"1900_CR77","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1128\/jcm.35.1.71-78.1997","volume":"35","author":"M Friedman-Einat","year":"1997","unstructured":"Friedman-Einat M, Grossman Z, Mileguir F, Smetana Z, Ashkenazi M, Barkai G, Varsano N, Glick E, Mendelson E. Detection of adeno-associated virus type 2 sequences in the human genital tract. J Clin Microbiol. 1997;35:71\u20138.","journal-title":"J Clin Microbiol"},{"key":"1900_CR78","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1016\/j.fertnstert.2003.08.020","volume":"81","author":"M Matovina","year":"2004","unstructured":"Matovina M, Husnjak K, Milutin N, Ciglar S, Grce M. Possible role of bacterial and viral infections in miscarriages. Fertil Steril. 2004;81:662\u20139.","journal-title":"Fertil Steril"},{"key":"1900_CR79","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1016\/S0015-0282(99)00363-5","volume":"72","author":"V Rohde","year":"1999","unstructured":"Rohde V, Erles K, Sattler HP, Derouet H, Wullich B, Schlehofer JR. Detection of adeno-associated virus in human semen: does viral infection play a role in the pathogenesis of male infertility? Fertil Steril. 1999;72:814\u20136.","journal-title":"Fertil Steril"},{"key":"1900_CR80","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.1093\/humrep\/16.11.2333","volume":"16","author":"K Erles","year":"2001","unstructured":"Erles K, Rohde V, Thaele M, Roth S, Edler L, Schlehofer JR. DNA of adeno-associated virus (AAV) in testicular tissue and in abnormal semen samples. Hum Reprod. 2001;16:2333\u20137.","journal-title":"Hum Reprod"},{"key":"1900_CR81","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1023\/B:VIRU.0000012264.54212.f5","volume":"28","author":"S Mehrle","year":"2004","unstructured":"Mehrle S, Rohde V, Schlehofer JR. Evidence of chromosomal integration of AAV DNA in human testis tissue. Virus Genes. 2004;28:61\u20139.","journal-title":"Virus Genes"},{"key":"1900_CR82","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1093\/humrep\/der427","volume":"27","author":"JR Schlehofer","year":"2012","unstructured":"Schlehofer JR, Boeke C, Reuland M, Eggert-Kruse W. Presence of DNA of adeno-associated virus in subfertile couples, but no association with fertility factors. Hum Reprod. 2012;27:770\u20138.","journal-title":"Hum Reprod"},{"key":"1900_CR83","unstructured":"International Agency for Research on Cancer. Globocan 2020. 11-Liver-fact-sheet.pdf. https:\/\/gco.iarc.fr\/today\/data\/factsheets\/cancers\/11-Liver-fact-sheet.pdf."},{"key":"1900_CR84","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41572-020-00240-3","volume":"7","author":"JM Llovet","year":"2021","unstructured":"Llovet JM, Kelley RK, Villanueva A, Singal AG, Pikarsky E, Roayaie S, Lencioni R, Koike K, Zucman-Rossi J, Finn RS. Hepatocellular carcinoma. Nat Rev Dis Primers. 2021;7:6.","journal-title":"Nat Rev Dis Primers"},{"key":"1900_CR85","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.jhep.2017.09.016","volume":"68","author":"N Fujiwara","year":"2018","unstructured":"Fujiwara N, Friedman SL, Goossens N, Hoshida Y. Risk factors and prevention of hepatocellular carcinoma in the era of precision medicine. J Hepatol. 2018;68:526\u201349.","journal-title":"J Hepatol"},{"key":"1900_CR86","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1001\/jamaoncol.2017.3055","volume":"3","author":"C Cancer","year":"2017","unstructured":"Global Burden of Disease Liver. Cancer C, Akinyemiju T, Abera S, Ahmed M, Alam N, Alemayohu MA, Allen C, Al-Raddadi R, Alvis-Guzman N, Amoako Y, et al: The Burden of Primary Liver Cancer and Underlying Etiologies From 1990 to 2015 at the Global, Regional, and National Level: Results From the Global Burden of Disease Study 2015. JAMA Oncol 2017, 3:1683\u201391.","journal-title":"JAMA Oncol"},{"key":"1900_CR87","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.coviro.2016.07.009","volume":"20","author":"E Shirvani-Dastgerdi","year":"2016","unstructured":"Shirvani-Dastgerdi E, Schwartz RE, Ploss A. Hepatocarcinogenesis associated with hepatitis B, delta and C viruses. Curr Opin Virol. 2016;20:1\u201310.","journal-title":"Curr Opin Virol"},{"key":"1900_CR88","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.jhep.2016.02.021","volume":"64","author":"M Levrero","year":"2016","unstructured":"Levrero M, Zucman-Rossi J. Mechanisms of HBV-induced hepatocellular carcinoma. J Hepatol. 2016;64:84\u2013101.","journal-title":"J Hepatol"},{"key":"1900_CR89","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1136\/gutjnl-2019-318281","volume":"69","author":"T La Bella","year":"2020","unstructured":"La Bella T, Imbeaud S, Peneau C, Mami I, Datta S, Bayard Q, Caruso S, Hirsch TZ, Calderaro J, Morcrette G, et al. Adeno-associated virus in the liver: natural history and consequences in tumour development. Gut. 2020;69:737\u201347.","journal-title":"Gut"},{"key":"1900_CR90","doi-asserted-by":"publisher","first-page":"6217","DOI":"10.1158\/1078-0432.CCR-18-4041","volume":"25","author":"K Tatsuno","year":"2019","unstructured":"Tatsuno K, Midorikawa Y, Takayama T, Yamamoto S, Nagae G, Moriyama M, Nakagawa H, Koike K, Moriya K, Aburatani H. Impact of AAV2 and Hepatitis B Virus Integration Into Genome on Development of Hepatocellular Carcinoma in Patients with Prior Hepatitis B Virus Infection. Clin Cancer Res. 2019;25:6217\u201327.","journal-title":"Clin Cancer Res"},{"key":"1900_CR91","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1038\/ng.3893","volume":"49","author":"GJ Logan","year":"2017","unstructured":"Logan GJ, Dane AP, Hallwirth CV, Smyth CM, Wilkie EE, Amaya AK, Zhu E, Khandekar N, Ginn SL, Liao SHY, et al. Identification of liver-specific enhancer-promoter activity in the 3\u2019 untranslated region of the wild-type AAV2 genome. Nat Genet. 2017;49:1267\u201373.","journal-title":"Nat Genet"},{"key":"1900_CR92","doi-asserted-by":"publisher","first-page":"5235","DOI":"10.1038\/s41467-018-07552-9","volume":"9","author":"Q Bayard","year":"2018","unstructured":"Bayard Q, Meunier L, Peneau C, Renault V, Shinde J, Nault JC, Mami I, Couchy G, Amaddeo G, Tubacher E, et al. Cyclin A2\/E1 activation defines a hepatocellular carcinoma subclass with a rearrangement signature of replication stress. Nat Commun. 2018;9:5235.","journal-title":"Nat Commun"},{"key":"1900_CR93","doi-asserted-by":"crossref","unstructured":"Peneau C, Zucman-Rossi J, Nault JC. Genomics of Viral Hepatitis-Associated Liver Tumors. J Clin Med 2021, 10.","DOI":"10.3390\/jcm10091827"},{"key":"1900_CR94","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1172\/JCI79213","volume":"125","author":"RJ Chandler","year":"2015","unstructured":"Chandler RJ, LaFave MC, Varshney GK, Trivedi NS, Carrillo-Carrasco N, Senac JS, Wu W, Hoffmann V, Elkahloun AG, Burgess SM, Venditti CP. Vector design influences hepatic genotoxicity after adeno-associated virus gene therapy. J Clin Invest. 2015;125:870\u201380.","journal-title":"J Clin Invest"},{"key":"1900_CR95","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1126\/science.1142658","volume":"317","author":"A Donsante","year":"2007","unstructured":"Donsante A, Miller DG, Li Y, Vogler C, Brunt EM, Russell DW, Sands MS. AAV vector integration sites in mouse hepatocellular carcinoma. Science. 2007;317:477.","journal-title":"Science"},{"key":"1900_CR96","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/s41587-020-0741-7","volume":"39","author":"GN Nguyen","year":"2021","unstructured":"Nguyen GN, Everett JK, Kafle S, Roche AM, Raymond HE, Leiby J, Wood C, Assenmacher CA, Merricks EP, Long CT, et al. A long-term study of AAV gene therapy in dogs with hemophilia A identifies clonal expansions of transduced liver cells. Nat Biotechnol. 2021;39:47\u201355.","journal-title":"Nat Biotechnol"},{"key":"1900_CR97","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.ymthe.2006.03.008","volume":"14","author":"P Bell","year":"2006","unstructured":"Bell P, Moscioni AD, McCarter RJ, Wu D, Gao G, Hoang A, Sanmiguel JC, Sun X, Wivel NA, Raper SE, et al. Analysis of tumors arising in male B6C3F1 mice with and without AAV vector delivery to liver. Mol Ther. 2006;14:34\u201344.","journal-title":"Mol Ther"},{"key":"1900_CR98","doi-asserted-by":"publisher","first-page":"3311","DOI":"10.1182\/blood-2010-08-302729","volume":"117","author":"H Li","year":"2011","unstructured":"Li H, Malani N, Hamilton SR, Schlachterman A, Bussadori G, Edmonson SE, Shah R, Arruda VR, Mingozzi F, Wright JF, et al. Assessing the potential for AAV vector genotoxicity in a murine model. Blood. 2011;117:3311\u20139.","journal-title":"Blood"},{"key":"1900_CR99","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1038\/mt.2015.174","volume":"23","author":"S Li","year":"2015","unstructured":"Li S, Ling C, Zhong L, Li M, Su Q, He R, Tang Q, Greiner DL, Shultz LD, Brehm MA, et al. Efficient and Targeted Transduction of Nonhuman Primate Liver With Systemically Delivered Optimized AAV3B Vectors. Mol Ther. 2015;23:1867\u201376.","journal-title":"Mol Ther"},{"key":"1900_CR100","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1089\/humc.2014.153","volume":"26","author":"TC Nichols","year":"2015","unstructured":"Nichols TC, Whitford MH, Arruda VR, Stedman HH, Kay MA, High KA. Translational data from adeno-associated virus-mediated gene therapy of hemophilia B in dogs. Hum Gene Ther Clin Dev. 2015;26:5\u201314.","journal-title":"Hum Gene Ther Clin Dev"},{"key":"1900_CR101","doi-asserted-by":"publisher","first-page":"469","DOI":"10.3343\/alm.2016.36.5.469","volume":"36","author":"KJ Park","year":"2016","unstructured":"Park KJ, Lee J, Park JH, Joh JW, Kwon CH, Kim JW. Adeno-Associated Virus 2-Mediated Hepatocellular Carcinoma is Very Rare in Korean Patients. Ann Lab Med. 2016;36:469\u201374.","journal-title":"Ann Lab Med"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-022-01900-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12985-022-01900-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-022-01900-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,31]],"date-time":"2022-10-31T18:12:33Z","timestamp":1667239953000},"score":1,"resource":{"primary":{"URL":"https:\/\/virologyj.biomedcentral.com\/articles\/10.1186\/s12985-022-01900-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,31]]},"references-count":101,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["1900"],"URL":"https:\/\/doi.org\/10.1186\/s12985-022-01900-4","relation":{},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,31]]},"assertion":[{"value":"9 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"173"}}